Adagene Inc. (ADAG)
NASDAQ: ADAG · IEX Real-Time Price · USD
2.510
-0.060 (-2.33%)
At close: Jul 19, 2024, 4:00 PM
2.640
+0.130 (5.18%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Adagene Market Cap
Adagene has a market cap or net worth of $110.74 million as of July 22, 2024. Its market cap has increased by 67.28% in one year.
Market Cap
110.74M
Enterprise Value
23.11M
1-Year Change
67.28%
Ranking
Category
Stock Price
$2.51
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $110.74M, a decrease of -86.23%. That is a compound annual growth rate of -43.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 110.00M | 30.02% |
| Dec 29, 2023 | 84.60M | 47.13% |
| Dec 30, 2022 | 57.50M | -83.10% |
| Dec 31, 2021 | 340.30M | -57.69% |
| Feb 9, 2021 | 804.22M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RAPT Therapeutics | 114.83M |
| TELA Bio | 114.15M |
| aTyr Pharma | 113.18M |
| Telomir Pharmaceuticals | 111.04M |
| Karyopharm Therapeutics | 110.91M |
| Augmedix | 110.67M |
| I-Mab | 110.14M |
| Elutia | 110.10M |